$67B Cigna-Express Scripts deal approved by final regulator

Cigna received its final approval from regulators for its $67 billion acquisition of Express Scripts. New Jersey approved the transaction, clearing the way for the deal to close, according to a public filing from Cigna.

“All required regulatory approvals now have been received and the parties expect to close the transaction on December 20, 2018, subject to the satisfaction of all other closing conditions,” the filing reads.

The transaction brings together a major health insurance provider with one of the nation’s largest pharmacy benefit managers. California and New York approved the deal on Dec. 13, but New Jersey remained as the last holdout.

The completion of the merger was originally anticipated to close by Dec. 8, but Cigna executives signaled the deal would be delayed in late November.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.